Research programme: prostate cancer therapy - Industrial Research/ Albert Einstein
Alternative Names: Prostate cancer therapy research programme - Industrial Research/Albert EinsteinLatest Information Update: 21 Nov 2006
Price :
$50 *
At a glance
- Originator Albert Einstein College of Medicine; Industrial Research Limited
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Prostate cancer
Most Recent Events
- 21 Nov 2006 Discontinued - Preclinical for Prostate cancer in New Zealand (unspecified route)
- 21 Nov 2006 Discontinued - Preclinical for Prostate cancer in USA (unspecified route)
- 01 Dec 2003 Preclinical trials in Prostate cancer in New Zealand (unspecified route)